Robert Wagner retweeted
⏰Have you registered for our #webinar? Join Jennifer Sargent (EiC of @Metabologia) & @SimonDreher1 (Associate Editor) introducing the EASD's new #journal live: from vision, submission & early career editorial opportunities.
📅 2 Jul 2026 | 16:00 CEST
🔗 us06web.zoom.us/webinar/regi…
Robert Wagner retweeted
📢 Join our @EASDacademy today! Are you an early-career researcher or clinician passionate about #diabetes #research & advancing the next generation of science? We are looking for new committee members!
📅 Deadline: 30 June 2026
👉 Apply now: easd.org/academy/academy-com…
#opencall

ALT An EASD Early Career Academy Committee Member Recruitment banner with a deep blue gradient background and curved light blue and white decorative elements in the top right corner. A red triangle in the top left corner displays "OPEN CALL!" in white text. The main heading reads "Join the Early Career Academy Committee," followed by the text: "Passionate about creating opportunities for early-career researchers and clinicians in diabetes? Apply now to help shape future activities and direction of the EASD Early Career Academy." The EASD Early Career Academy logo appears in a white footer bar at the bottom left, alongside the website easd.org/academy at the bottom right.
Robert Wagner retweeted
Very important paper, #PancreasLovers!!!!!
International Multidisciplinary Consensus Report onDefinitions, Diagnostic Criteria, and Management of FattyPancreas @UEGJournal @albrechtneesse @my_ueg @EurPancClub @ESGE_news
👇👇👇
onlinelibrary.wiley.com/doi/…
Our interdisciplinary team used #explainableAI to distinguish type 2 #diabetes vs no T2D directly from human pancreas tissue—where humans typically can’t. Key insight: signals go beyond beta cells (α/δ, nerves) and pancreatic fat matters. Thanks to all nature.com/articles/s41467-0…
Congratulations to Martin Schön @MartinSchon1990 for the Prevention Prize of the German Society of Internal Medicine. May the 4th be with you, and may your research prevent #diabetes complications. #DGIM @DiabResearch
Homage to Ludwik Zamenhof, the creator of #esperanto, who was born in #Bialystok . His dream of a universal language was a truly congenial idea for a divided world. Can English be a substitute?
Advancing our partnership in precision prevention and diabetes treatment with the Medical University of Bialystok. Impressive facilities and exciting studies underway! Grateful to @l_szczerbinski, Vice Rector Adam Kretowski, and the team for the warm hospitality.
Ever wondered why processed foods might be so unhealthy? It’s more than just calories. Turns out carrageenan, a common food additive, can make your gut leaky. And also more... Read about our study we did with @DrNorbertStefan and others @DiabResearch link.springer.com/article/10…
Robert Wagner retweeted
Happy to share our press release eurekalert.org/news-releases… 'The cardiometabolic risk of a higher #BMI may be underestimated in #taller grown #populations worldwide' about our Research Letter addressing the impact of changes in #height and #obesity on risk of #diabetes
🌟Congrats to @MaHeUlm who has been awarded the prestigious Friedrich-Arnold-Gries-Prize by the German Diabetes Association @DDG_Tweets. His groundbreaking research on the central nervous system's role in regulating peripheral metabolism continues to inspire! @DiabResearch
Robert Wagner retweeted
A review by @MaHeUlm discusses the impact of brain insulin resistance on whole-body metabolism, body fat distribution and cognition, and its role in high-risk phenotypes and potential therapeutic options @uni_ulm #Minkowski Prize tinyurl.com/54h997d8 🔓
Robert Wagner retweeted
Following our review on metabolic implications of intra-pancreatic fat two years ago (nature.com/articles/s41574-0…), now accumulating evidence of a causal link to pancreatic cancer. Proud to contribute alongside Hajime Yamazaki and all co-authors. @wagrob
doi.org/10.1016/j.xcrm.2023.…
Robert Wagner retweeted
Can Glucagon-like peptide-1 receptor agonist treatment reverse diabetic neuropathy?
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 105th NEUROdiab Publication News is by Gidon J Bönhof (neurodiab.eu/publication-new…)
In this paper @MartinSchon1990 applied an innovative algorithm to stratify persons with #T2D from routine variables to depict metabolic heterogeneity of #diabetes. Great collab with the group of @ezpearson #GDS @ddz_info @DiabResearch #LURIC w/ W. März. authors.elsevier.com/a/1iIM3…
So highly deserved. But not only her scientific work is outstanding, she is also a wonderful person. youtu.be/FiXHgJ_rHXM?feature…
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Robert Wagner retweeted
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Robert Wagner retweeted
Exciting insights from our research: Brain insulin action boosts peripheral insulin sensitivity in women, but intriguingly, only during the follicular phase of the menstrual cycle.
@Steph_Kullmann @DiabResearch @uni_ulm
go.nature.com/3ZtwbeL
Robert Wagner retweeted
#ADA2023 Thrilled to share our exciting progress on brain insulin's role in peripheral metabolism and its resistance during the luteal phase of the menstrual cycle. Kudos to brilliant Julia Hummel for this exceptional work! #WomenInScience @uni_ulm @Steph_Kullmann @DiabResearch
It was a great honour to meet Sir George Alberti in person at the #DUKPC2023. He had revolutionalized the treatment of DKA over 50 years ago. Thx @ShivaniM_KC for introducing us.























